Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

No abstract is available for this paper.

• Publication year

  1971

• Venue

  Unknown venue

• Publication date

  1971-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Paradoxical Effect of Grape Pomace Extract on Cisplatin-Induced Acute Kidney Injury in Rats

  2019cites this paper
• Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges

  2018cites this paper
• Cisplatyna : dokumentacja proponowanych dopuszczalnych wielkości narażenia zawodowego

  2018cites this paper
• Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy

  2018cites this paper
• Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity

  2017cites this paper
• Use of an organotypic mammalian in vitro follicle growth assay to facilitate female reproductive toxicity screening.

  2016cites this paper
• Hydrogen sulfide: A novel nephroprotectant against cisplatin-induced renal toxicity.

  2016cites this paper
• An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.

  2016cites this paper
• A STUDY OF RENAL FUN CTION PROFILE DURING COURSE OF COMBINATION CHEMOTHE RAPY OF GERM CELL TU MOR

  2015cites this paper
• Toxicity to Host-renewing Cell Populations in Rats Cis-Dichlorodiammineplatinum(II) Antitumor Activity and Effects of Mannitol or Furosemide Diuresis on

  2013cites this paper
• Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.

  2013cites this paper
• Xenobiotic Effects on Ovarian Preantral Follicles1

  2011cites this paper
• The effect of cytotoxic chemotherapy on the structural and material properties of regenerate bone in a rabbit model of limb lengthening

  2011cites this paper
• Mechanisms of Cisplatin Nephrotoxicity

  2010cites this paper
• Actual and potential agents and biomarkers in the treatment of cancer.

  2009cites this paper
• Fluid and diuretic therapy for preventing cisplatin‐induced nephrotoxicity

  2008cites this paper
• GENE EXPRESSION KINETICS AND PROTEIN DISTRIBUTION OF NUCLEOTIDE EXCISION REPAIR FACTORS IN THE INNER EAR AS A FUNCTION OF cis-DIAMMINEDICHLOROPLATINUM-II DNA DAMAGE

  2006cites this paper
• Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.

  2006cites this paper
• Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage.

  2006cites this paper
• Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats

  2005cites this paper
• Effect of cisplatin upon expression of in vivo immune tumor resistance

  2005cites this paper
• Bullatacin — in vivo and in vitro experience in an ovarian cancer model

  2004cites this paper
• Cyclophosphamide and cis-dichlorodiammine platinum (11)

  2004cites this paper
• Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II)

  2004cites this paper
• Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum (II), CDDP) in BD IX rats

  2004cites this paper
• Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin

  2004cites this paper
• Cytotoxicity assessment of three therapeutic agents, cyclosporin-A, cisplatin and doxorubicin, with the ciliated protozoan Tetrahymena pyriformis.

  2003cites this paper
• Melatonin: reducing the toxicity and increasing the efficacy of drugs

  2002cites this paper
• Blood-perilymph barrier and ototoxicity: an in vivo study in the rat.

  2000cites this paper
• Mechanism of cisplatin ototoxicity: antioxidant system.

  1995cites this paper
• Effect of cisplatin administration on the electrochemical composition of endolymph in the rat cochlea.

  1995cites this paper
• Discovery of Improved Platinum Analogues

  1994cites this paper
• A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat

  1994cites this paper
• Reduction of Cisplatinum-Induced Renal Toxicity in Mice by Tetrahydroindazolone Carboxylic Acid (HIDA)

  1993cites this paper
• Carboplatin ototoxicity: an animal model

  1993cites this paper
• Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds.

  1992cites this paper
• The Urinary Tract

  1991cites this paper
• Toxicity of cis-diamminedichloroplatinum (II) (cisplatin) in the frog, Rana pipiens.

  1990cites this paper
• L-methionine suppresses pathological sequelae of cis-platinum in the rat.

  1990cites this paper
• Assessment of Toxicologic Effects upon Bone Marrow and Related Tissues

  1990cites this paper
• Clastogenic effects of cis-diamminedichloroplatinum. I. Induction of chromosomal aberrations in somatic and germinal cells of mice.

  1989cites this paper
• A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat.

  1989cites this paper
• Supplemental Fosfomycin and/or Steroids that Reduce Cisplatin‐Induced Nephrotoxicity

  1988cites this paper
• The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle.

  1988cites this paper
• Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.

  1987cites this paper
• Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat.

  1987cites this paper
• Cisplatin, Platinum Analogues, and Other Heavy Metal Complexes

  1987cites this paper
• Clinical and Experimental Nephrotoxicity of Cancer Chemotherapeutic Agents

  1987cites this paper
• Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity.

  1986cites this paper
• Pattern of toxicity by titanocene dichloride in mice

  1986cites this paper
• Renal damage in mice after treatment with cisplatinum alone or in combination with X-irradiation.

  1986cites this paper
• Charles F. Kettring prize. Fundamental studies with cisplatin

  1985cites this paper
• Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide

  1985cites this paper
• cis-Diamminedichloroplatinum(II): effects of a representative metal coordination complex on mammalian cells.

  1984cites this paper
• Platinum Analogues: Criteria for Selection

  1983cites this paper
• Is there cumulative or delayed toxicity from Cis‐platinum?

  1983cites this paper
• The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function.

  1983cites this paper
• Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration.

  1982cites this paper
• cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment.

  1981cites this paper
• Gel filtration of urine: a method to detect nephrotoxicity in rats.

  1981cites this paper
• Methods of reduction of cisplatin nephrotoxicity.

  1981cites this paper
• Urinary gamma-glutamyl transferase as an indicator of acute nephrotoxicity in rats

  1981cites this paper
• THE EFFECT OF HEAVY METAL CHELATORS ON THE RENAL ACCUMULATION OF PLATINUM AFTER cis‐DICHLORO‐DIAMMINEPLATINUM II ADMINISTRATION TO THE RAT

  1981cites this paper
• Nephrotoxicity of cis-diamminedichloroplatinum (II) (cis-platinum) and the additive effect of antibiotics: morphological and functional observation in rats.

  1981cites this paper
• Effectsof Mannitolor FurosemideDiuresison the Nephrotoxicityand PhysiologicalDispositionof cis-Dichlorodiammineplatinum-(ll) in Rats1

  1979cites this paper
• Antineoplastic Drugs: Clinical Pharmacology and Therapeutic Use

  1978cites this paper
• The renal pathology in clinical trials of Cis‐platinum (II) diamminedichloride

  1977cites this paper
• Classification of Chemotherapeutic Agents According to their Mechanisms of Action

  1976cites this paper
• The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats.

  1976cites this paper
• Interactions of platinum metals and their complexes in biological systems.

  1975cites this paper
• Anti-Tumour Effects of Platinum Complexes in Experimental Animals

  1974cites this paper
• Phase I clinical trial of combined therapy with 5‐FU (NSC 19893) and cis‐platinum (II) diaminedichloride (NSC 119875)

  1974cites this paper
• Phase I Evaluation of cis-Platinum (II) Diamminedichloride (PDD) and a Combination of PDD Plus Adriamycin

  1974cites this paper
• Preliminary Report on Phase 1 Clinical Experience with Combined cis-diamminedichloride Platinum (II) (PDD) and 5-FU

  1974cites this paper
• Preliminary clinical experience with cis‐diamminedichloroplatinum (II) (NSC 119875, CACP)

  1972cites this paper
• The interaction of plantinum II compounds with bacteriophages T7 and R17.

  1972cites this paper